

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.28820235 |
| 2 | behavioral response to nicotine (GO:0035095) | 4.17980333 |
| 3 | nucleobase catabolic process (GO:0046113) | 3.73730785 |
| 4 | central nervous system myelination (GO:0022010) | 3.60147344 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 3.60147344 |
| 6 | synaptic vesicle maturation (GO:0016188) | 3.48373762 |
| 7 | vocalization behavior (GO:0071625) | 3.35715301 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.34096937 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 3.32737427 |
| 10 | locomotory exploration behavior (GO:0035641) | 3.31815840 |
| 11 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.31026549 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.29043301 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.25766659 |
| 14 | dendrite morphogenesis (GO:0048813) | 3.22401809 |
| 15 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.21180992 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.20067051 |
| 17 | neuronal ion channel clustering (GO:0045161) | 3.18215578 |
| 18 | piRNA metabolic process (GO:0034587) | 3.14441176 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.13041497 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.11239254 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 3.08784111 |
| 22 | gamma-aminobutyric acid transport (GO:0015812) | 3.07463286 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.07148571 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.02365281 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 3.01488125 |
| 26 | glutamate secretion (GO:0014047) | 2.97952571 |
| 27 | synaptic vesicle exocytosis (GO:0016079) | 2.92475402 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.88129521 |
| 29 | protein localization to synapse (GO:0035418) | 2.87557557 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.85594562 |
| 31 | neuron recognition (GO:0008038) | 2.83570225 |
| 32 | neuromuscular synaptic transmission (GO:0007274) | 2.82435228 |
| 33 | startle response (GO:0001964) | 2.80855838 |
| 34 | positive regulation of synapse assembly (GO:0051965) | 2.79443312 |
| 35 | adult walking behavior (GO:0007628) | 2.79200472 |
| 36 | short-term memory (GO:0007614) | 2.78904445 |
| 37 | multicellular organismal signaling (GO:0035637) | 2.78643892 |
| 38 | central nervous system neuron axonogenesis (GO:0021955) | 2.77849265 |
| 39 | exploration behavior (GO:0035640) | 2.77522445 |
| 40 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.77477690 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 2.77364777 |
| 42 | regulation of membrane repolarization (GO:0060306) | 2.75941190 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 2.75872797 |
| 44 | axonal fasciculation (GO:0007413) | 2.72335287 |
| 45 | neuron maturation (GO:0042551) | 2.68597769 |
| 46 | response to pheromone (GO:0019236) | 2.68396094 |
| 47 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.68167458 |
| 48 | positive regulation of meiosis (GO:0045836) | 2.67450673 |
| 49 | L-phenylalanine catabolic process (GO:0006559) | 2.67014122 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.67014122 |
| 51 | neuronal action potential (GO:0019228) | 2.66597461 |
| 52 | mechanosensory behavior (GO:0007638) | 2.65064023 |
| 53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.61678507 |
| 54 | regulation of synaptic vesicle transport (GO:1902803) | 2.61210768 |
| 55 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.60633099 |
| 56 | nonmotile primary cilium assembly (GO:0035058) | 2.59112350 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.57080500 |
| 58 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.56387726 |
| 59 | neurotransmitter secretion (GO:0007269) | 2.56276366 |
| 60 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.53809915 |
| 61 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.53728256 |
| 62 | proline transport (GO:0015824) | 2.52977239 |
| 63 | adult behavior (GO:0030534) | 2.51682700 |
| 64 | behavioral response to ethanol (GO:0048149) | 2.49996927 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.49860455 |
| 66 | DNA methylation involved in gamete generation (GO:0043046) | 2.49442096 |
| 67 | neurofilament cytoskeleton organization (GO:0060052) | 2.48108074 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.47151996 |
| 69 | regulation of neurotransmitter secretion (GO:0046928) | 2.45147356 |
| 70 | positive regulation of meiotic cell cycle (GO:0051446) | 2.44609360 |
| 71 | activation of protein kinase A activity (GO:0034199) | 2.44587784 |
| 72 | cochlea development (GO:0090102) | 2.43971299 |
| 73 | regulation of synapse assembly (GO:0051963) | 2.43640651 |
| 74 | regulation of respiratory system process (GO:0044065) | 2.43472645 |
| 75 | retinal cone cell development (GO:0046549) | 2.43107886 |
| 76 | serotonin metabolic process (GO:0042428) | 2.42902742 |
| 77 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.42629065 |
| 78 | positive regulation of action potential (GO:0045760) | 2.42358422 |
| 79 | positive regulation of dendritic spine development (GO:0060999) | 2.41528554 |
| 80 | action potential (GO:0001508) | 2.41253105 |
| 81 | synaptic transmission (GO:0007268) | 2.40896683 |
| 82 | behavioral defense response (GO:0002209) | 2.39038060 |
| 83 | behavioral fear response (GO:0001662) | 2.39038060 |
| 84 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.38978907 |
| 85 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.38840175 |
| 86 | long-term memory (GO:0007616) | 2.38273220 |
| 87 | ketone body metabolic process (GO:1902224) | 2.37626946 |
| 88 | neuronal action potential propagation (GO:0019227) | 2.36863560 |
| 89 | presynaptic membrane assembly (GO:0097105) | 2.34708006 |
| 90 | L-phenylalanine metabolic process (GO:0006558) | 2.33114984 |
| 91 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.33114984 |
| 92 | nerve growth factor signaling pathway (GO:0038180) | 2.31693027 |
| 93 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.27689814 |
| 94 | regulation of dendritic spine development (GO:0060998) | 2.27484359 |
| 95 | glutamate receptor signaling pathway (GO:0007215) | 2.26536732 |
| 96 | establishment of mitochondrion localization (GO:0051654) | 2.26507225 |
| 97 | synaptic transmission, glutamatergic (GO:0035249) | 2.25993337 |
| 98 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.25814429 |
| 99 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.25515718 |
| 100 | cell migration in hindbrain (GO:0021535) | 2.23744595 |
| 101 | auditory behavior (GO:0031223) | 2.22983794 |
| 102 | aromatic amino acid family catabolic process (GO:0009074) | 2.22820637 |
| 103 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.21881593 |
| 104 | bile acid biosynthetic process (GO:0006699) | 2.20181484 |
| 105 | membrane depolarization during action potential (GO:0086010) | 2.19430510 |
| 106 | neuron-neuron synaptic transmission (GO:0007270) | 2.18756171 |
| 107 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.18392176 |
| 108 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.17482195 |
| 109 | presynaptic membrane organization (GO:0097090) | 2.17323783 |
| 110 | clathrin coat assembly (GO:0048268) | 2.17245010 |
| 111 | fatty acid transmembrane transport (GO:1902001) | 2.16791686 |
| 112 | response to auditory stimulus (GO:0010996) | 2.16558287 |
| 113 | establishment of nucleus localization (GO:0040023) | 2.16411148 |
| 114 | regulation of postsynaptic membrane potential (GO:0060078) | 2.15457437 |
| 115 | cerebellar granule cell differentiation (GO:0021707) | 2.15186398 |
| 116 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.13275938 |
| 117 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.12971071 |
| 118 | carnitine shuttle (GO:0006853) | 2.12600637 |
| 119 | positive regulation of synapse maturation (GO:0090129) | 2.12004712 |
| 120 | * axon extension (GO:0048675) | 2.11698932 |
| 121 | complement activation, alternative pathway (GO:0006957) | 2.11013957 |
| 122 | alanine transport (GO:0032328) | 2.08672094 |
| 123 | transmission of nerve impulse (GO:0019226) | 2.08571852 |
| 124 | organelle transport along microtubule (GO:0072384) | 2.08419862 |
| 125 | regulation of ARF protein signal transduction (GO:0032012) | 2.08204884 |
| 126 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.07013689 |
| 127 | neuromuscular process controlling balance (GO:0050885) | 2.05813977 |
| 128 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.04186317 |
| 129 | mitochondrion transport along microtubule (GO:0047497) | 2.04186317 |
| 130 | calcium ion-dependent exocytosis (GO:0017156) | 2.04066545 |
| 131 | neurotransmitter transport (GO:0006836) | 2.03919475 |
| 132 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.03884132 |
| 133 | postsynaptic membrane organization (GO:0001941) | 2.03601338 |
| 134 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.03287649 |
| 135 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.02956645 |
| 136 | regulation of female receptivity (GO:0045924) | 2.02772432 |
| 137 | synapse assembly (GO:0007416) | 2.02706223 |
| 138 | response to methylmercury (GO:0051597) | 2.02647470 |
| 139 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.02413050 |
| 140 | synapse organization (GO:0050808) | 2.02354839 |
| 141 | membrane depolarization (GO:0051899) | 2.01847650 |
| 142 | glutamate metabolic process (GO:0006536) | 1.98901119 |
| 143 | regulation of synaptic plasticity (GO:0048167) | 1.98852130 |
| 144 | L-amino acid import (GO:0043092) | 1.98078672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.81017514 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.88093877 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.25607517 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23645868 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09029055 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.05134254 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01725597 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.98903984 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.98903984 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95553901 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93096120 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.92628046 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87980626 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86737827 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83130965 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.80749364 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.76653659 |
| 18 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.74260716 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72996191 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69772863 |
| 21 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.68066420 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66362781 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65722921 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65129378 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64916513 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61293313 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60053220 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57844885 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.57428204 |
| 30 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48259507 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46740843 |
| 32 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.45752996 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42283731 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41215554 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40400015 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39871897 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37938743 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37482859 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37423049 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36951390 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36723021 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35801871 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34227464 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33405313 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33219734 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32702158 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32326792 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30059754 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28478126 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27812408 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27665023 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27576251 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27145475 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26193657 |
| 55 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26164801 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25905444 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25035278 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24683471 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24222547 |
| 60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24157991 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22110982 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18498423 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17910766 |
| 64 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16316682 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15684726 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15357656 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14332475 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14228619 |
| 69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14226387 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13563162 |
| 71 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12794136 |
| 72 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12531661 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10900545 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10892385 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10763114 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10098542 |
| 77 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08673634 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08151513 |
| 79 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.08005719 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07544110 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04906672 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04099774 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03073620 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03073620 |
| 85 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02740014 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02449598 |
| 87 | AR_19668381_ChIP-Seq_PC3_Human | 1.01838933 |
| 88 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01711723 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01579494 |
| 90 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00857284 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00837629 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00636162 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99769081 |
| 94 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99689949 |
| 95 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99118035 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99040646 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98415626 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98232813 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97878312 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97793562 |
| 101 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97595838 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97290569 |
| 103 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97219837 |
| 104 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96860614 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96608778 |
| 106 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96011025 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95551387 |
| 108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95359070 |
| 109 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95221156 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94943726 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94943726 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94781391 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94420378 |
| 114 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91169158 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90763453 |
| 116 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90279483 |
| 117 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90206936 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89610037 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89277815 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89277815 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89171492 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89162725 |
| 123 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87233064 |
| 124 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86694698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.39187827 |
| 2 | MP0004270_analgesia | 3.30787240 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.90556505 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 2.90272365 |
| 5 | MP0003880_abnormal_central_pattern | 2.73987385 |
| 6 | MP0002063_abnormal_learning/memory/cond | 2.45116424 |
| 7 | MP0005360_urolithiasis | 2.35521291 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.31142972 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.28593190 |
| 10 | MP0009745_abnormal_behavioral_response | 2.27156938 |
| 11 | MP0002064_seizures | 2.18514580 |
| 12 | MP0002822_catalepsy | 2.16952259 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.15085280 |
| 14 | MP0001486_abnormal_startle_reflex | 2.08488855 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.07373741 |
| 16 | MP0004130_abnormal_muscle_cell | 2.06515606 |
| 17 | MP0005365_abnormal_bile_salt | 2.02054871 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 1.95186380 |
| 19 | MP0001968_abnormal_touch/_nociception | 1.94020109 |
| 20 | MP0003329_amyloid_beta_deposits | 1.93003021 |
| 21 | MP0000778_abnormal_nervous_system | 1.92984523 |
| 22 | * MP0002572_abnormal_emotion/affect_behav | 1.92847501 |
| 23 | MP0009046_muscle_twitch | 1.86964189 |
| 24 | MP0000751_myopathy | 1.86931810 |
| 25 | MP0003690_abnormal_glial_cell | 1.80519191 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.79830889 |
| 27 | MP0002102_abnormal_ear_morphology | 1.77003320 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.73189752 |
| 29 | MP0002272_abnormal_nervous_system | 1.71527033 |
| 30 | MP0004885_abnormal_endolymph | 1.69173305 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60846218 |
| 32 | MP0003787_abnormal_imprinting | 1.59295615 |
| 33 | MP0000920_abnormal_myelination | 1.58808019 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.57421138 |
| 35 | MP0004924_abnormal_behavior | 1.54179507 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.54179507 |
| 37 | MP0005410_abnormal_fertilization | 1.50572973 |
| 38 | MP0003633_abnormal_nervous_system | 1.46697590 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.44855368 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.44410613 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.42756663 |
| 42 | MP0004145_abnormal_muscle_electrophysio | 1.41087262 |
| 43 | MP0000566_synostosis | 1.40694364 |
| 44 | MP0003252_abnormal_bile_duct | 1.40567294 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.39763177 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.38975825 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.38963072 |
| 48 | MP0003136_yellow_coat_color | 1.35924539 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.35219918 |
| 50 | MP0008569_lethality_at_weaning | 1.34871737 |
| 51 | MP0002736_abnormal_nociception_after | 1.34805747 |
| 52 | MP0000604_amyloidosis | 1.29913599 |
| 53 | MP0004811_abnormal_neuron_physiology | 1.27621398 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.26233138 |
| 55 | MP0002557_abnormal_social/conspecific_i | 1.26019944 |
| 56 | MP0004858_abnormal_nervous_system | 1.24881808 |
| 57 | MP0001970_abnormal_pain_threshold | 1.24537291 |
| 58 | MP0000955_abnormal_spinal_cord | 1.24314292 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.22941358 |
| 60 | MP0002184_abnormal_innervation | 1.22372818 |
| 61 | MP0004133_heterotaxia | 1.22160285 |
| 62 | MP0001984_abnormal_olfaction | 1.20618430 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 1.19290927 |
| 64 | MP0002752_abnormal_somatic_nervous | 1.18187931 |
| 65 | MP0003631_nervous_system_phenotype | 1.17508663 |
| 66 | MP0003283_abnormal_digestive_organ | 1.14843854 |
| 67 | MP0003122_maternal_imprinting | 1.14300420 |
| 68 | MP0000026_abnormal_inner_ear | 1.13222484 |
| 69 | * MP0005535_abnormal_body_temperature | 1.11743294 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 1.11542444 |
| 71 | MP0001299_abnormal_eye_distance/ | 1.11315834 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.11124435 |
| 73 | MP0001485_abnormal_pinna_reflex | 1.09501032 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.08381629 |
| 75 | MP0004085_abnormal_heartbeat | 1.06330134 |
| 76 | MP0003634_abnormal_glial_cell | 1.05061952 |
| 77 | MP0001529_abnormal_vocalization | 1.04257732 |
| 78 | MP0002882_abnormal_neuron_morphology | 1.03890050 |
| 79 | MP0001963_abnormal_hearing_physiology | 1.03434496 |
| 80 | MP0003879_abnormal_hair_cell | 1.02687389 |
| 81 | MP0004036_abnormal_muscle_relaxation | 1.01023879 |
| 82 | MP0004215_abnormal_myocardial_fiber | 1.00566982 |
| 83 | MP0001188_hyperpigmentation | 0.99322931 |
| 84 | MP0000747_muscle_weakness | 0.98047399 |
| 85 | MP0005620_abnormal_muscle_contractility | 0.97599984 |
| 86 | MP0010030_abnormal_orbit_morphology | 0.97551449 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.94932092 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.93011102 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.92611219 |
| 90 | MP0001177_atelectasis | 0.92314681 |
| 91 | MP0006292_abnormal_olfactory_placode | 0.91730729 |
| 92 | MP0003890_abnormal_embryonic-extraembry | 0.90984496 |
| 93 | MP0002090_abnormal_vision | 0.90479752 |
| 94 | MP0004484_altered_response_of | 0.90440247 |
| 95 | MP0002229_neurodegeneration | 0.90422577 |
| 96 | MP0000749_muscle_degeneration | 0.89527384 |
| 97 | MP0008874_decreased_physiological_sensi | 0.89512384 |
| 98 | MP0003646_muscle_fatigue | 0.88721638 |
| 99 | MP0000049_abnormal_middle_ear | 0.86704308 |
| 100 | MP0004742_abnormal_vestibular_system | 0.86616541 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.86501128 |
| 102 | MP0003075_altered_response_to | 0.85654869 |
| 103 | MP0001905_abnormal_dopamine_level | 0.85187467 |
| 104 | MP0005187_abnormal_penis_morphology | 0.84537432 |
| 105 | MP0003632_abnormal_nervous_system | 0.84526338 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.83985556 |
| 107 | MP0003861_abnormal_nervous_system | 0.83976177 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.83889126 |
| 109 | MP0005332_abnormal_amino_acid | 0.83052312 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82445209 |
| 111 | MP0003698_abnormal_male_reproductive | 0.82115356 |
| 112 | MP0003868_abnormal_feces_composition | 0.81642482 |
| 113 | MP0003121_genomic_imprinting | 0.81173719 |
| 114 | MP0002152_abnormal_brain_morphology | 0.80853945 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.79334765 |
| 116 | MP0005195_abnormal_posterior_eye | 0.79075642 |
| 117 | MP0004142_abnormal_muscle_tone | 0.76640892 |
| 118 | MP0005253_abnormal_eye_physiology | 0.75698691 |
| 119 | MP0005409_darkened_coat_color | 0.75138830 |
| 120 | MP0002160_abnormal_reproductive_system | 0.74454908 |
| 121 | MP0004087_abnormal_muscle_fiber | 0.73742098 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.73253504 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.72679989 |
| 124 | MP0003938_abnormal_ear_development | 0.72658156 |
| 125 | MP0010386_abnormal_urinary_bladder | 0.72020752 |
| 126 | MP0003195_calcinosis | 0.70875636 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.70597123 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.68915196 |
| 129 | MP0002972_abnormal_cardiac_muscle | 0.68905240 |
| 130 | MP0005499_abnormal_olfactory_system | 0.68637991 |
| 131 | MP0005394_taste/olfaction_phenotype | 0.68637991 |
| 132 | MP0005670_abnormal_white_adipose | 0.67982589 |
| 133 | MP0002938_white_spotting | 0.67110809 |
| 134 | MP0005623_abnormal_meninges_morphology | 0.66520843 |
| 135 | MP0003119_abnormal_digestive_system | 0.65868893 |
| 136 | MP0001502_abnormal_circadian_rhythm | 0.65761525 |
| 137 | MP0005083_abnormal_biliary_tract | 0.63833903 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.63790660 |
| 139 | MP0002078_abnormal_glucose_homeostasis | 0.63262159 |
| 140 | MP0005551_abnormal_eye_electrophysiolog | 0.63072605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 3.96816393 |
| 2 | Neurofibrillary tangles (HP:0002185) | 3.82383140 |
| 3 | Hyperventilation (HP:0002883) | 3.76234861 |
| 4 | Myokymia (HP:0002411) | 3.69965709 |
| 5 | Cerebral inclusion bodies (HP:0100314) | 3.43200403 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 3.24126510 |
| 7 | Complement deficiency (HP:0004431) | 3.22161812 |
| 8 | Focal seizures (HP:0007359) | 3.21494089 |
| 9 | Nephronophthisis (HP:0000090) | 3.17787611 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.17318718 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.15870570 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.09654095 |
| 13 | Abnormality of midbrain morphology (HP:0002418) | 3.09654095 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.08089168 |
| 15 | Termporal pattern (HP:0011008) | 3.05064883 |
| 16 | Insidious onset (HP:0003587) | 3.05064883 |
| 17 | Gait imbalance (HP:0002141) | 3.03336990 |
| 18 | Action tremor (HP:0002345) | 2.90001289 |
| 19 | Visual hallucinations (HP:0002367) | 2.84570316 |
| 20 | Pancreatic fibrosis (HP:0100732) | 2.81215617 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.75616885 |
| 22 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.75616885 |
| 23 | Ankle clonus (HP:0011448) | 2.73538464 |
| 24 | Medial flaring of the eyebrow (HP:0010747) | 2.72295194 |
| 25 | Genetic anticipation (HP:0003743) | 2.72042184 |
| 26 | Poor eye contact (HP:0000817) | 2.68500058 |
| 27 | Abnormality of the renal medulla (HP:0100957) | 2.68271803 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.65988896 |
| 29 | Mutism (HP:0002300) | 2.65391863 |
| 30 | Broad-based gait (HP:0002136) | 2.63805654 |
| 31 | Epileptic encephalopathy (HP:0200134) | 2.62867370 |
| 32 | True hermaphroditism (HP:0010459) | 2.59078407 |
| 33 | Urinary urgency (HP:0000012) | 2.58826046 |
| 34 | Abnormal social behavior (HP:0012433) | 2.58101919 |
| 35 | Impaired social interactions (HP:0000735) | 2.58101919 |
| 36 | Intention tremor (HP:0002080) | 2.56468128 |
| 37 | Epidermoid cyst (HP:0200040) | 2.55421356 |
| 38 | Type II lissencephaly (HP:0007260) | 2.52401042 |
| 39 | Generalized tonic-clonic seizures (HP:0002069) | 2.50933820 |
| 40 | Excessive salivation (HP:0003781) | 2.50643368 |
| 41 | Drooling (HP:0002307) | 2.50643368 |
| 42 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.48261523 |
| 43 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.48261523 |
| 44 | Torticollis (HP:0000473) | 2.47882195 |
| 45 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.47601708 |
| 46 | Pancreatic cysts (HP:0001737) | 2.45943201 |
| 47 | Chronic hepatic failure (HP:0100626) | 2.43813824 |
| 48 | Abnormal ciliary motility (HP:0012262) | 2.42924735 |
| 49 | Congenital primary aphakia (HP:0007707) | 2.40031968 |
| 50 | Spastic gait (HP:0002064) | 2.37950342 |
| 51 | Hyperlipoproteinemia (HP:0010980) | 2.35309627 |
| 52 | Fetal akinesia sequence (HP:0001989) | 2.34877635 |
| 53 | Postural instability (HP:0002172) | 2.34099198 |
| 54 | Progressive cerebellar ataxia (HP:0002073) | 2.32856191 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.32796391 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.32571401 |
| 57 | Atonic seizures (HP:0010819) | 2.32344140 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.27358648 |
| 59 | Dysdiadochokinesis (HP:0002075) | 2.26976264 |
| 60 | Nephrogenic diabetes insipidus (HP:0009806) | 2.26337940 |
| 61 | Prolonged QT interval (HP:0001657) | 2.22678485 |
| 62 | Xanthomatosis (HP:0000991) | 2.21536217 |
| 63 | Dysmetria (HP:0001310) | 2.20933827 |
| 64 | Inability to walk (HP:0002540) | 2.20805082 |
| 65 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.20081842 |
| 66 | Difficulty running (HP:0009046) | 2.20076600 |
| 67 | Hyporeflexia of lower limbs (HP:0002600) | 2.19911899 |
| 68 | Ketosis (HP:0001946) | 2.18862669 |
| 69 | Prolonged partial thromboplastin time (HP:0003645) | 2.18561043 |
| 70 | Genital tract atresia (HP:0001827) | 2.17332413 |
| 71 | Anxiety (HP:0000739) | 2.13579128 |
| 72 | Hemiparesis (HP:0001269) | 2.13375721 |
| 73 | Scanning speech (HP:0002168) | 2.12786339 |
| 74 | Pheochromocytoma (HP:0002666) | 2.12677253 |
| 75 | Depression (HP:0000716) | 2.12548339 |
| 76 | Absence seizures (HP:0002121) | 2.12453426 |
| 77 | Vaginal atresia (HP:0000148) | 2.12085995 |
| 78 | Protruding tongue (HP:0010808) | 2.10660882 |
| 79 | Amyotrophic lateral sclerosis (HP:0007354) | 2.10482331 |
| 80 | Blue irides (HP:0000635) | 2.09997696 |
| 81 | Focal dystonia (HP:0004373) | 2.09663017 |
| 82 | Papilledema (HP:0001085) | 2.08694322 |
| 83 | Poor coordination (HP:0002370) | 2.06611888 |
| 84 | Oligodactyly (hands) (HP:0001180) | 2.06258086 |
| 85 | Absent/shortened dynein arms (HP:0200106) | 2.04903992 |
| 86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.04903992 |
| 87 | Anterior segment dysgenesis (HP:0007700) | 2.04853546 |
| 88 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.04512968 |
| 89 | Sudden death (HP:0001699) | 2.03516660 |
| 90 | Ketoacidosis (HP:0001993) | 2.03222915 |
| 91 | Lissencephaly (HP:0001339) | 2.03172811 |
| 92 | Retinal dysplasia (HP:0007973) | 2.02545151 |
| 93 | Craniofacial dystonia (HP:0012179) | 2.02401393 |
| 94 | Inappropriate behavior (HP:0000719) | 2.02222143 |
| 95 | Congenital stationary night blindness (HP:0007642) | 2.01134416 |
| 96 | Abnormal eating behavior (HP:0100738) | 2.00830247 |
| 97 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.00741210 |
| 98 | Abnormal EKG (HP:0003115) | 1.97013965 |
| 99 | Febrile seizures (HP:0002373) | 1.96465168 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 1.96123295 |
| 101 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.95969918 |
| 102 | Impaired vibratory sensation (HP:0002495) | 1.95470737 |
| 103 | Dialeptic seizures (HP:0011146) | 1.94811058 |
| 104 | Pachygyria (HP:0001302) | 1.94509860 |
| 105 | Sleep apnea (HP:0010535) | 1.94134611 |
| 106 | Akinesia (HP:0002304) | 1.93010148 |
| 107 | Specific learning disability (HP:0001328) | 1.92183834 |
| 108 | Megalencephaly (HP:0001355) | 1.92050912 |
| 109 | Calf muscle hypertrophy (HP:0008981) | 1.91476030 |
| 110 | Truncal ataxia (HP:0002078) | 1.90530128 |
| 111 | Progressive inability to walk (HP:0002505) | 1.90347140 |
| 112 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89550183 |
| 113 | Spastic tetraplegia (HP:0002510) | 1.89302953 |
| 114 | Abnormality of complement system (HP:0005339) | 1.88471106 |
| 115 | Abnormality of binocular vision (HP:0011514) | 1.87356197 |
| 116 | Diplopia (HP:0000651) | 1.87356197 |
| 117 | Amblyopia (HP:0000646) | 1.87027234 |
| 118 | Hemiplegia (HP:0002301) | 1.86927960 |
| 119 | Polyphagia (HP:0002591) | 1.86129222 |
| 120 | Cystic liver disease (HP:0006706) | 1.84389519 |
| 121 | Gaze-evoked nystagmus (HP:0000640) | 1.84093186 |
| 122 | Increased corneal curvature (HP:0100692) | 1.83769120 |
| 123 | Keratoconus (HP:0000563) | 1.83769120 |
| 124 | Epileptiform EEG discharges (HP:0011182) | 1.82672107 |
| 125 | Cerebral hemorrhage (HP:0001342) | 1.82263032 |
| 126 | EEG with generalized epileptiform discharges (HP:0011198) | 1.81987674 |
| 127 | Agitation (HP:0000713) | 1.80538181 |
| 128 | Hypoalphalipoproteinemia (HP:0003233) | 1.80516895 |
| 129 | Hypsarrhythmia (HP:0002521) | 1.80041269 |
| 130 | Abnormal drinking behavior (HP:0030082) | 1.79848280 |
| 131 | Polydipsia (HP:0001959) | 1.79848280 |
| 132 | Shawl scrotum (HP:0000049) | 1.79701561 |
| 133 | Neuronal loss in central nervous system (HP:0002529) | 1.79310057 |
| 134 | Decreased central vision (HP:0007663) | 1.78927616 |
| 135 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.78917826 |
| 136 | Limb dystonia (HP:0002451) | 1.78354244 |
| 137 | Anencephaly (HP:0002323) | 1.77799328 |
| 138 | Spastic tetraparesis (HP:0001285) | 1.77065063 |
| 139 | Macroorchidism (HP:0000053) | 1.76531357 |
| 140 | Exotropia (HP:0000577) | 1.75480457 |
| 141 | Syncope (HP:0001279) | 1.74977612 |
| 142 | Postaxial hand polydactyly (HP:0001162) | 1.73996800 |
| 143 | Fair hair (HP:0002286) | 1.73918325 |
| 144 | Neuroendocrine neoplasm (HP:0100634) | 1.71592312 |
| 145 | Short tibia (HP:0005736) | 1.70780644 |
| 146 | Onion bulb formation (HP:0003383) | 1.69684314 |
| 147 | Generalized myoclonic seizures (HP:0002123) | 1.69580853 |
| 148 | Absent speech (HP:0001344) | 1.68688570 |
| 149 | Status epilepticus (HP:0002133) | 1.68594898 |
| 150 | Increased variability in muscle fiber diameter (HP:0003557) | 1.68516693 |
| 151 | Widely spaced teeth (HP:0000687) | 1.68117216 |
| 152 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.68095390 |
| 153 | Neoplasm of the adrenal cortex (HP:0100641) | 1.67023027 |
| 154 | Obstructive sleep apnea (HP:0002870) | 1.66833011 |
| 155 | Abnormality of the calf musculature (HP:0001430) | 1.64598089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.52514178 |
| 2 | EPHA4 | 2.79092578 |
| 3 | MAP3K4 | 2.28456705 |
| 4 | NTRK3 | 2.26644186 |
| 5 | PHKG2 | 2.20014656 |
| 6 | PHKG1 | 2.20014656 |
| 7 | DAPK2 | 2.01222466 |
| 8 | MAP3K9 | 1.93051273 |
| 9 | PRKD3 | 1.89568903 |
| 10 | MINK1 | 1.85175178 |
| 11 | MAP2K4 | 1.82139466 |
| 12 | PAK6 | 1.79146066 |
| 13 | MAP2K7 | 1.76526163 |
| 14 | CASK | 1.63789061 |
| 15 | MAPK13 | 1.61883055 |
| 16 | NTRK2 | 1.58683765 |
| 17 | NTRK1 | 1.50170203 |
| 18 | PDK3 | 1.42321642 |
| 19 | PDK4 | 1.42321642 |
| 20 | PKN1 | 1.37371075 |
| 21 | PDK2 | 1.35188895 |
| 22 | CDK19 | 1.34970091 |
| 23 | CAMK1G | 1.34364330 |
| 24 | FGFR2 | 1.31875614 |
| 25 | CAMKK1 | 1.31252057 |
| 26 | ADRBK2 | 1.29739574 |
| 27 | TNIK | 1.27222261 |
| 28 | WNK3 | 1.26025203 |
| 29 | SIK2 | 1.25963268 |
| 30 | CDK5 | 1.23962903 |
| 31 | KSR2 | 1.22159487 |
| 32 | STK39 | 1.17249977 |
| 33 | PINK1 | 1.12823614 |
| 34 | SGK223 | 1.12471778 |
| 35 | SGK494 | 1.12471778 |
| 36 | MAPK15 | 1.12467882 |
| 37 | BMPR1B | 1.12261683 |
| 38 | ERBB3 | 1.11272070 |
| 39 | MAPK12 | 1.11013724 |
| 40 | INSRR | 1.10946021 |
| 41 | KSR1 | 1.07080584 |
| 42 | RET | 1.06565367 |
| 43 | TYRO3 | 1.04050560 |
| 44 | PRKCH | 1.03557024 |
| 45 | PTK2B | 1.03494755 |
| 46 | CSNK1G2 | 1.03288913 |
| 47 | PAK3 | 1.02588025 |
| 48 | PLK2 | 0.99069979 |
| 49 | CAMK4 | 0.96478363 |
| 50 | SGK3 | 0.92802191 |
| 51 | SGK2 | 0.92069199 |
| 52 | GRK5 | 0.91274691 |
| 53 | EPHB2 | 0.90769273 |
| 54 | STK11 | 0.90656082 |
| 55 | OXSR1 | 0.87313436 |
| 56 | SIK1 | 0.86983456 |
| 57 | MARK2 | 0.86859049 |
| 58 | PRPF4B | 0.86575686 |
| 59 | RIPK1 | 0.86054167 |
| 60 | TGFBR2 | 0.85105890 |
| 61 | ICK | 0.84401334 |
| 62 | GRK1 | 0.83330396 |
| 63 | CAMK2A | 0.83273112 |
| 64 | DMPK | 0.82106621 |
| 65 | PDK1 | 0.79973777 |
| 66 | PRKCG | 0.79353559 |
| 67 | ACVR1B | 0.79146840 |
| 68 | BCR | 0.79113774 |
| 69 | STK38 | 0.78283807 |
| 70 | MAP3K2 | 0.77739526 |
| 71 | WNK1 | 0.77357374 |
| 72 | TRIB3 | 0.76420968 |
| 73 | UHMK1 | 0.75199405 |
| 74 | LMTK2 | 0.72001189 |
| 75 | PDPK1 | 0.71943483 |
| 76 | DYRK2 | 0.71800615 |
| 77 | OBSCN | 0.70455074 |
| 78 | PRKCZ | 0.70200167 |
| 79 | CAMK1D | 0.70170283 |
| 80 | TTN | 0.68868181 |
| 81 | CSNK1A1L | 0.68562916 |
| 82 | LATS2 | 0.67876515 |
| 83 | TAOK3 | 0.67769458 |
| 84 | RPS6KA2 | 0.64723527 |
| 85 | MAP3K7 | 0.63867910 |
| 86 | TNK2 | 0.63306883 |
| 87 | SGK1 | 0.63306047 |
| 88 | WNK4 | 0.61894064 |
| 89 | PRKCE | 0.60834987 |
| 90 | ADRBK1 | 0.59833760 |
| 91 | RIPK4 | 0.58184998 |
| 92 | CSNK1G3 | 0.57772713 |
| 93 | FES | 0.57694189 |
| 94 | EPHB1 | 0.57667794 |
| 95 | PKN2 | 0.57579618 |
| 96 | CAMK2B | 0.57251848 |
| 97 | GRK7 | 0.55994986 |
| 98 | MAP4K2 | 0.54822724 |
| 99 | PRKAA1 | 0.51826900 |
| 100 | PRKACA | 0.51737328 |
| 101 | ROCK1 | 0.51302900 |
| 102 | DYRK1A | 0.51006680 |
| 103 | FYN | 0.50854213 |
| 104 | PIK3CA | 0.49801761 |
| 105 | PNCK | 0.49534654 |
| 106 | CAMK1 | 0.48985053 |
| 107 | PRKG1 | 0.48888673 |
| 108 | MAP3K6 | 0.48665851 |
| 109 | CAMKK2 | 0.48110912 |
| 110 | NEK6 | 0.47369064 |
| 111 | PRKD1 | 0.47063615 |
| 112 | CDK3 | 0.46861912 |
| 113 | EPHA3 | 0.46791058 |
| 114 | PDGFRA | 0.45690089 |
| 115 | FRK | 0.43856615 |
| 116 | CSNK1G1 | 0.43377459 |
| 117 | DYRK1B | 0.42892203 |
| 118 | CDK15 | 0.42845468 |
| 119 | RPS6KA3 | 0.40179233 |
| 120 | CAMK2G | 0.39867637 |
| 121 | MAPKAPK5 | 0.38674015 |
| 122 | DYRK3 | 0.37247305 |
| 123 | CAMK2D | 0.36957699 |
| 124 | PDGFRB | 0.36710720 |
| 125 | ERBB2 | 0.36091296 |
| 126 | PRKCQ | 0.35456762 |
| 127 | RPS6KB1 | 0.35449605 |
| 128 | PRKACB | 0.33791133 |
| 129 | PRKCA | 0.32310161 |
| 130 | STK38L | 0.32134708 |
| 131 | CSNK1D | 0.31409687 |
| 132 | CDK11A | 0.31112871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70906014 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.05561424 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99135713 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 1.91335923 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83477009 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.81349932 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.67258049 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.59817986 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.59495060 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 1.56258000 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 1.55906940 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.50824428 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50102697 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45648537 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44323647 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40924452 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.38781876 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38490511 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37382042 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.36943163 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.33767601 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.30466732 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25920500 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.25816059 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22359147 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22043372 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.21611412 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.19707393 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19572216 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.17251641 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16422745 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14145425 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12584083 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12511524 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.11565375 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09193369 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09169479 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.07478457 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07448400 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05383273 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05274550 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05175988 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02329849 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02239979 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99659069 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98787312 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96812940 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.94275754 |
| 49 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.93420799 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93265306 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93134792 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92813269 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90207935 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90099922 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89821729 |
| 56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88549985 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87331137 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86734490 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.85486486 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85441678 |
| 61 | Long-term depression_Homo sapiens_hsa04730 | 0.85342380 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85141695 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83426621 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82705529 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80537823 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78736038 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78483369 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78243406 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75317121 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74736773 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.74492167 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73783961 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73564301 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72509307 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.71766802 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.71459022 |
| 77 | * Regulation of autophagy_Homo sapiens_hsa04140 | 0.71425197 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69632171 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68523109 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68486155 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.68473103 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68161843 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67416202 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66715372 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66619933 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65266398 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64600306 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64329457 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63119715 |
| 90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63037133 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62997931 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.62354521 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62335712 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61696596 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61288125 |
| 96 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60465321 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58745512 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58163431 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57942603 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57705708 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57595213 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56984899 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56732759 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56640692 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56458655 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56379546 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56267083 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55900867 |
| 109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54520410 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.54149054 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52703587 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52477865 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.52184646 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50114408 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49809105 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48031598 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47924050 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46099307 |
| 119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46045845 |
| 120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45988008 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44117987 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43875787 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43287321 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42209499 |
| 125 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41508816 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41468190 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40946524 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40652816 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39869751 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39834351 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39787421 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39430464 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37102187 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.34967464 |

